681 to 690 of 2,329 Results
Tabular Data - 110.9 KB - 95 Variables, 1003 Observations - UNF:6:k4IJy7yCvXUlQGEeTQbb1Q==
|
MS Word - 16.5 KB -
MD5: 2cf2307e4dc02f27652a35416c056027
Table of antibodies used |
SVG Image - 7.0 MB -
MD5: 35d7775a9ad2b8e738aa63dbeb076111
Analysis of autofluorescence in paraffin-embedded tissues |
SVG Image - 4.2 MB -
MD5: da372999c0490a5af94b2b537aea082c
Comparison between direct and indirect immunofluorescence in paraffin-embedded tissues. |
SVG Image - 1.7 MB -
MD5: 7b6e308ca4882f2c58de22fd684ffcdf
Analysis of primary cells cocultured with MSCs. |
SVG Image - 35.2 MB -
MD5: c0bde7a2e12690dcbe8f55e7887f8b4a
Analysis of biomarkers within different tumor microenvironments. |
Mar 24, 2025 -
Antineoplastic effects of β-carboline derivatives in chronic and acute myeloid leukemia
Unknown - 14.5 MB -
MD5: f3fc489b3d53f340f7c1dc67bbe36f3a
Autophagic processes analysis. Leukemia cell lines were treated with β-carboline derived compounds. Cells positive for Acridine Orange (AO) were analyzed by flow cytometry. |
Mar 24, 2025 -
Antineoplastic effects of β-carboline derivatives in chronic and acute myeloid leukemia
Unknown - 8.6 MB -
MD5: 3e3ecd15f075721cd1090fd9d26c24a0
Apoptosis analysis. Leukemia cell lines were treated with β-carboline compounds. Annexin V + / PI + cells were analyzed by flow cytometry. |
Mar 24, 2025 -
Antineoplastic effects of β-carboline derivatives in chronic and acute myeloid leukemia
MS Word - 86.9 KB -
MD5: e742ff52e596c91a7497565c18bb9f92
Structure of the 12 β-carboline derived compounds investigated in this study (1 – 12). |
Mar 24, 2025 -
Antineoplastic effects of β-carboline derivatives in chronic and acute myeloid leukemia
HTML - 22.0 KB -
MD5: f2cf5123ef217107078c96e29ec1d0b9
GI50 of leukemia cell lines treated with β-carboline derived compounds. GI50 determined from cell viability assays. |
